Philips Files 6-K Report
Ticker: RYLPF · Form: 6-K · Filed: Oct 28, 2024 · CIK: 313216
Sentiment: neutral
Topics: 6-K, foreign-issuer, reporting
TL;DR
Philips filed a 6-K, standard foreign issuer report. Nothing major to see here.
AI Summary
Koninklijke Philips N.V. filed a Form 6-K on October 28, 2024, reporting information as of the same date. The filing is for a foreign issuer and indicates that Philips will file annual reports under Form 20-F. The company's principal executive offices are located at Breitner Center, Amstelplein 2, 1096 BC Amsterdam, The Netherlands.
Why It Matters
This filing provides routine updates for foreign issuers, signaling ongoing compliance and reporting for Koninklijke Philips N.V. to the SEC.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign issuer and does not contain specific financial results or material events.
Key Players & Entities
- KONINKLIJKE PHILIPS NV (company) — Registrant
- Royal Philips (company) — Registrant's name in English
- Breitner Center, Amstelplein 2, 1096 BC Amsterdam, The Netherlands (company) — Principal executive offices
FAQ
What type of filing is this?
This is a Form 6-K, a Report of Foreign Issuer.
Who is the registrant?
The registrant is Koninklijke Philips N.V., also known as Royal Philips.
Where are the company's principal executive offices located?
The principal executive offices are located at Breitner Center, Amstelplein 2, 1096 BC Amsterdam, The Netherlands.
What is the jurisdiction of incorporation or organization for the registrant?
The jurisdiction of incorporation or organization is The Netherlands.
Does the registrant file annual reports under Form 20-F or Form 40-F?
The registrant indicates it files annual reports under Form 20-F.
Filing Stats: 4,330 words · 17 min read · ~14 pages · Grade level 11.3 · Accepted 2024-10-28 09:12:34
Filing Documents
- phg-20240930.htm (6-K) — 465KB
- visual0001.jpg (GRAPHIC) — 34KB
- visual0002.jpg (GRAPHIC) — 77KB
- 0000313216-24-000018.txt ( ) — 598KB
Forward-looking statements and other important information
Forward-looking statements and other important information
Forward-looking statements
Forward-looking statements This document and the related oral presentation, including responses to questions following the presentation, contain certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about strategy, estimates of sales growth, future Adjusted EBITA * ) , future restructuring and acquisition related charges and other costs, future developments in Philips’ organic business and the completion of acquisitions and divestments. Forward-looking statements can be identified generally as those containing words such as “anticipates”, “assumes”, “believes”, “estimates”, “expects”, “should”, “will”, “will likely result”, “forecast”, “outlook”, “projects”, “may” or similar expressions. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.  These factors include but are not limited to: Philips’ ability to gain leadership in health informatics in response to developments in the health technology industry; Philips’ ability to keep pace with the changing health technology environment; macro-economic and geopolitical changes; integration of acquisitions and their delivery on business plans and value creation expectations; securing and maintaining Philips’ intellectual property rights, and unauthorized use of third-party intellectual property rights; Philips’ ability to meet expectations with respect to ESG-related matters; failure of products and